Novo Nordisk is expanding its use of artificial intelligence and Amazon Web Services (AWS) technology across drug discovery, with a focus on AI agents for identifying drug targets, designing therapies, and streamlining research workflows. Under a newly announced agreement, AWS will become Novo Nordisk’s preferred cloud provider and strategic AI https://landlordservices81435.bloggazzo.com/41367045/strong-novo-nordisk-and-aws-expand-agentic-ai-use-across-drug-discovery-strong